Home Five Innovative Medical Devices Enter Special Review Program Amid IPO Filings

Five Innovative Medical Devices Enter Special Review Program Amid IPO Filings

Apr 03, 2026 17:41 CST Updated 17:41
Zylox-Tonbridge

Innovative R&D, Production, and Sales of Medical Devices in the Vascular Intervention Field

WYTD

Developer of Cardiac Disease Diagnosis and Treatment Equipment

V-Onco

Irreversible Electroporation Technology Developer

图片

National Medical Products Administration Releases "Public Notice of the Review Results for the Special Review Application of Innovative Medical Devices (No. 6, 2026)》, the following application projects are proposed to be approved to enter the special review process. The public announcement period will be from April 1 to April 16, 2026.

1. Product Name: Peripheral Dot Stent System

Applicant: Zylox-Tonbridge Medical Technology Co., Ltd.


2. Product Name: Ceramic Dental Implant System

Applicant: Beijing Ruici Medical Technology Co., Ltd.


3. Product Name: Patent Foramen Ovale (PFO) Closure Device

Applicant: WYTD MEDICAL TECHNOLOGY (SHENZHEN) CO., LTD.


4. Product Name: Steep Pulse Treatment Device

Applicant: Hangzhou V-Onco Medical Technology Co., Ltd.


5. Product Name: Toric Posterior Chamber Phakic Intraocular Lens

Applicant: Wuxi Carl Zeiss Rayming Vision Healthcare Technology Co., Ltd.


Recommended Reading

Review Report of the First Invasive Brain-Computer Interface Product


A Company Suspended Import Due to Non-conformity of System


Two Innovative Products Approved for Marketing


A Guiding Principle for Class III Medical Devices

Image